CASEIN KINASE 1 INHIBITORS FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Science. Official publication website can be found on muni.cz.

Authors	BRYJA Vítězslav KAUCKÁ Markéta PLEVOVÁ Karla PAVLOVÁ Šárka POSPÍŠILOVÁ Šárka KOZUBÍK Alois
Year of publication	2016
Type	Patent
MU Faculty or unit	Faculty of Science
Publisher	Canadian Intellectual Property Office
State	Canada
Patent's number	CA 2876908
Web	http://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/2876908/summary.html
Description	The invention provides new medicaments for the treatment of the B-cell chronic lymphocytic leukemia, which are inhibitors of casein kinase 1.
Related projects:	Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies Úloha nekanonické Wnt signalizace v molekulární patogenezi chronické lymfocytární leukémie Molekulární mechanismy nekanonické Wnt signalizace v leukémii